Gonococcal conjunctivitis is a bacterial eye infection caused by Neisseria gonorrhoeae, the same organism responsible for the sexually transmitted infection gonorrhea. It stands apart from garden-variety pink eye because the bacterium can invade intact corneal tissue, making it one of the few forms of conjunctivitis that can destroy an eye within days if left untreated. The infection occurs in both newborns (passed from mother to child during birth) and adults (usually through hand-to-eye transfer of genital secretions), and while it is uncommon in countries with widespread STI screening, it has not disappeared.
How the Infection Reaches the Eye
In adults, the most common route is autoinoculation: a person with genital gonorrhea touches infected secretions and then touches their eye. A case report illustrating this scenario described a man who presented with a painful, swollen eye and was found to also have gonococcal urethritis he had not yet sought treatment for.1PubMed Central. Gonorrhoea presenting as red eye: Rare case Direct sexual contact with infected genital secretions can also introduce the bacteria to the conjunctiva, though this is less commonly reported. Shared towels or contaminated fingers during intimate contact are plausible but poorly documented vectors.
In newborns, the route is more straightforward. The baby picks up N. gonorrhoeae while passing through an infected birth canal. The transmission rate from an infected mother to her newborn is estimated at roughly 30 to 50 percent, and the resulting neonatal infection tends to be more severe and appear earlier than eye infections caused by chlamydia.2PubMed Central. Epidemiology and control of gonococcal ophthalmia neonatorum
What Makes It So Aggressive
Most bacteria that cause conjunctivitis need an existing scratch or break in the corneal surface to gain a foothold. N. gonorrhoeae does not. It can penetrate intact corneal epithelium, which allows it to invade deeper tissue with alarming speed.3Nature (Eye). Don’t forget Gonococcus! This ability to bore through healthy tissue is what separates gonococcal conjunctivitis from the many milder forms of bacterial pink eye that resolve on their own or with simple antibiotic drops.
When the infection reaches the cornea, it can cause peripheral thinning, ulceration, and ultimately perforation, where the cornea develops a hole. A case series of three patients, all men between the ages of 19 and 49, documented exactly this progression. Each arrived with purulent discharge and vision loss, and each was found to have a perforated cornea by the time they were examined. One of the patients also had active urethral discharge, confirming the genital origin of the infection.4PubMed Central. Perforated Corneal Ulcer Arising From Gonococcal Keratoconjunctivitis: A Report of Three Cases If the infection spreads inside the eye after perforation, it can cause endophthalmitis, an internal eye infection that frequently leads to permanent blindness.
Recognizing the Symptoms
Gonococcal conjunctivitis does not look like ordinary pink eye. The hallmark is a copious, thick, purulent (pus-like) discharge that can accumulate rapidly, sometimes reappearing minutes after being wiped away. The eyelids swell dramatically, and the eye becomes intensely red and painful. Vision often deteriorates quickly. In adults, the infection is usually unilateral at first, starting in whichever eye was inoculated, though it can spread to the other eye if the person keeps touching their face.
In newborns, the presentation is similar but appears within the first few days of life, typically between two and five days after delivery. Both eyes are commonly affected. The volume of discharge in a neonate can be striking relative to the size of the infant’s face, and the lids may be so swollen that the baby cannot open them.
The speed of onset matters clinically. A patient who goes from a mildly red eye to severe swelling and thick discharge within 24 to 48 hours should raise immediate suspicion for gonococcal infection, especially if there is any sexual history suggesting gonorrhea exposure.
Getting the Diagnosis Right
Because the stakes are high and the window for treatment is narrow, identifying the causative organism quickly is critical. The traditional first step is a Gram stain of the discharge, which can reveal gram-negative diplococci (pairs of round bacteria) consistent with N. gonorrhoeae. This provides a presumptive diagnosis within minutes and is enough to start treatment.
Culture on chocolate agar remains the gold standard for confirming the organism and testing its antibiotic susceptibility. However, culture takes time, and newer nucleic acid amplification tests (NAATs) offer a faster alternative. A recent evaluation of NAAT performance for detecting gonorrhea in conjunctival swabs found sensitivity and specificity both around 92 percent, making it a reliable tool.5PubMed Central. Diagnosis of chlamydial and gonococcal conjunctivitis: performance evaluation of a nucleic acid amplification test NAATs are especially useful when the Gram stain is ambiguous or the clinical picture is complicated by possible co-infection with chlamydia.
One diagnostic pitfall worth knowing about: Neisseria meningitidis, a close relative of the gonorrhea bacterium, can also cause purulent conjunctivitis that mimics the gonococcal version. A case report described an adult patient whose meningococcal conjunctivitis initially looked mild, more like ordinary bacterial pink eye, and could easily have been missed. The danger with meningococcal eye infections is that the bacterium can spread to the bloodstream and brain, so early identification through culture or molecular testing matters.6PubMed Central. Primary meningococcal conjunctivitis in an adult patient
Treatment Requires Systemic Antibiotics
Unlike most forms of bacterial conjunctivitis, which respond to antibiotic eye drops alone, gonococcal conjunctivitis requires systemic treatment. Eye drops or ointment alone cannot reliably clear an organism capable of penetrating the cornea and potentially spreading to the bloodstream.7PubMed Central. Conjunctivitis: a systematic review of diagnosis and treatment The standard regimen in most guidelines centers on intramuscular ceftriaxone, a third-generation cephalosporin. Topical antibiotic irrigation of the eye is used alongside systemic therapy to reduce the bacterial load on the ocular surface.
Because gonorrhea and chlamydia frequently travel together as co-infections, guidelines from both the American Academy of Ophthalmology and the CDC recommend that adults treated for gonococcal conjunctivitis also receive anti-chlamydial coverage, typically a single oral dose of azithromycin or a seven-day course of doxycycline.8PubMed Central. Adult conjunctivitis secondary to dual infection with Chlamydia trachomatis and Neisseria gonorrhoeae – A case report This dual approach serves two purposes: it treats any undetected chlamydial co-infection, and the azithromycin historically provided a second mechanism of action against gonorrhea itself.
Treatment for sexual partners is equally important. A five-year review of gonococcal eye infections in Scotland found that all patients were referred to sexual health services, but only about half actually attended for full STI testing and contact tracing. Among those who did attend, one was found to have concurrent syphilis.9Nature (Eye). Five-year review of ocular Neisseria gonorrhoeae infections presenting to ophthalmology departments in Greater Glasgow & Clyde, Scotland That low follow-through rate highlights a persistent gap between what clinicians recommend and what actually happens in practice.
The Growing Threat of Drug Resistance
The treatment landscape for gonococcal infections, eye or otherwise, is complicated by the bacterium’s remarkable ability to develop antibiotic resistance. N. gonorrhoeae has progressively become resistant to sulfonamides, penicillins, tetracyclines, and fluoroquinolones over the past several decades, leaving ceftriaxone as one of the last reliable first-line options. That reliability is now being tested.
Ceftriaxone-resistant gonorrhea strains were first identified in Japan in 2011 and have since been reported in India, China, France, Australia, and Spain.10PubMed Central. Conjunctivitis Caused by a Strain of Neisseria gonorrhoeae That Was Less Susceptible to Ceftriaxone One Japanese surveillance report found that while outright resistance remained uncommon, about one in ten gonorrhea strains showed reduced susceptibility to ceftriaxone. The same report noted that in Fukuoka, Japan, nearly 23 percent of gonorrhea strains were resistant to azithromycin, raising the possibility that the standard ceftriaxone-plus-azithromycin combination may eventually lose effectiveness.
This has already played out in eye infections specifically. A report of two patients with gonococcal conjunctivitis described strains that did not respond to ceftriaxone eye drops or intravenous ceftriaxone. The patients’ conditions only improved after adding oral minocycline. Genetic analysis revealed the strains carried a mosaic penA gene, a known driver of reduced susceptibility to beta-lactam antibiotics like cephalosporins.11PubMed Central. Conjunctivitis caused by Neisseria gonorrhoeae isolates with reduced cephalosporin susceptibility and multidrug resistance For an infection that can perforate a cornea within days, drug resistance isn’t an abstract concern. A few days of ineffective treatment could be the difference between keeping an eye and losing it.
Newborn Prophylaxis and Its Complicated History
The practice of applying medication to a newborn’s eyes immediately after birth traces back to 1881, when the German obstetrician Carl Credé introduced 2 percent silver nitrate drops. Before that intervention, gonococcal eye infection in newborns was a leading cause of childhood blindness, accounting for a large share of residents in nineteenth-century institutions for the blind. Credé’s prophylaxis reduced the incidence of gonococcal ophthalmia neonatorum from roughly 10 percent to less than 0.5 percent.12PubMed Central. Interventions for preventing ophthalmia neonatorum
Silver nitrate was eventually replaced in many settings by antibiotic ointments, primarily erythromycin. The Italian Journal of Pediatrics noted that Neisseria gonorrhoeae was historically the most common cause of neonatal conjunctivitis and that this declined after widespread adoption of prophylaxis at birth.13PubMed Central. OPHTHALMIA NEONATORUM in Italy: it is time for change However, the effectiveness of these agents against chlamydia, which has surpassed gonorrhea as the more common cause of neonatal conjunctivitis in many countries, has been questioned. A study comparing silver nitrate, tetracycline, erythromycin, and no prophylaxis in over 4,500 newborns found that none of the prophylactic agents significantly reduced the rate of neonatal chlamydial conjunctivitis compared to no treatment at all.14Pediatric Infectious Disease Journal. Prophylaxis of ophthalmia neonatorum: comparison of silver nitrate, tetracycline, erythromycin and no prophylaxis
A separate randomized trial did find that silver nitrate lowered overall conjunctivitis rates in newborns by about 39 percent, and erythromycin by about 31 percent, compared to no prophylaxis, though the erythromycin result did not reach statistical significance.15Pediatrics. Randomized Trial of Silver Nitrate, Erythromycin, and No Eye Prophylaxis for the Prevention of Conjunctivitis Among Newborns Not at Risk for Gonococcal Ophthalmitis The distinction matters: these agents appear to reduce conjunctivitis from organisms other than chlamydia (including gonococcus) but fall short against the chlamydial strains that now dominate in many settings.
The Debate Over Universal Newborn Eye Drops
In the United States, erythromycin eye ointment at birth remains legally mandated in many states, a policy that dates to an era when prenatal screening for gonorrhea was inconsistent and the risk of neonatal gonococcal blindness was higher. Several other high-income countries, including Canada, the United Kingdom, and several European nations, have moved away from universal prophylaxis and toward risk-based approaches, where eye treatment is reserved for babies whose mothers tested positive for gonorrhea or who did not receive prenatal care.
A 2025 review in the Journal of Obstetric, Gynecologic & Neonatal Nursing argued that risk-based prevention models already adopted in many high-income countries offer a safer and more evidence-aligned alternative to universal erythromycin prophylaxis, especially given advances in prenatal STI screening and growing concerns about antibiotic stewardship.16PubMed. Reevaluating Neonatal Erythromycin Prophylaxis Policy Amid Advances in Sexually Transmitted Infection Screening, Antenatal Treatment, and Antibiotic Stewardship The argument is straightforward: if a pregnant person is screened and treated for gonorrhea during pregnancy, the risk of neonatal transmission drops dramatically, and exposing every newborn to an antibiotic that doesn’t effectively prevent chlamydial conjunctivitis may do more harm than good from a resistance standpoint. The counterargument is equally direct: screening misses some infections, not all pregnant people receive adequate prenatal care, and the consequences of a missed case of gonococcal ophthalmia neonatorum are devastating.
Why Gonococcal Conjunctivitis Gets Missed in Adults
One of the persistent problems with this infection is that clinicians who don’t see it regularly may not think of it. Adult gonococcal conjunctivitis is uncommon enough in well-resourced healthcare systems that it falls off the mental checklist. A patient presenting with a very red, painful eye and heavy discharge may be diagnosed with generic bacterial conjunctivitis and sent home with antibiotic drops. If the discharge is attributed to allergies, a viral infection, or a routine bacterial cause, systemic antibiotics are never started, and the infection progresses.
Several factors should raise a clinician’s suspicion: the sheer volume and purulence of the discharge, the rapidity of symptom onset, severe lid swelling, and any concurrent genital symptoms or history of STI exposure. The problem is that patients don’t always volunteer sexual history in an ophthalmology or urgent care setting, and clinicians don’t always ask. In the Scottish five-year review, the connection to genital gonorrhea was sometimes only established after the eye culture came back positive and the patient was referred to sexual health services.
For patients, the practical takeaway is that a violently red eye with thick yellow or greenish discharge that worsens over hours, especially if accompanied by any genital symptoms, warrants urgent evaluation. Waiting a few days to “see if it gets better” is reasonable for mild pink eye but dangerous with gonococcal conjunctivitis. If you have active gonorrhea or a recent exposure and develop eye symptoms, tell the treating clinician about the STI, even if it feels unrelated. That single piece of information can change the diagnosis and treatment within minutes.
Global Burden and Where It Persists
In high-income countries with strong prenatal screening programs, gonococcal ophthalmia neonatorum has become rare. But globally, the picture is different. A systematic review and meta-analysis evaluating ophthalmia neonatorum across over a million live births found a global incidence of about 2 percent, though with enormous variation between settings.17PubMed Central. Epidemiology of ophthalmia neonatorum: a systematic review and meta-analysis The prevalence among affected populations was substantially higher. This figure includes all causes of neonatal conjunctivitis, not just gonococcal, but it underscores that in parts of sub-Saharan Africa, South Asia, and other regions where prenatal care access is limited, neonatal eye infections remain a meaningful cause of preventable blindness.
Adult gonococcal conjunctivitis, meanwhile, tends to track with gonorrhea rates in the general population. Countries experiencing rising gonorrhea incidence, which includes the United States, the United Kingdom, and Australia in recent years, should expect to see occasional eye cases as well. The infection will never be common in absolute terms, but it doesn’t need to be. Even a handful of cases per year in a region can cause permanent vision loss if they aren’t recognized and treated promptly.
Living With the Aftermath
When gonococcal conjunctivitis is caught early and treated aggressively, outcomes are generally good. The infection clears, the eye heals, and vision returns to normal. The trouble is with delayed cases. A corneal perforation that gets plugged by iris tissue may heal enough to avoid evisceration (removal of the eye’s contents), but the resulting scar can permanently impair vision. Some patients need corneal transplants months or years later. In the worst scenarios, endophthalmitis following perforation leads to a blind or non-functional eye that may eventually require surgical removal.
There is also a psychological and social dimension that gets little attention in the medical literature. Being diagnosed with gonococcal conjunctivitis means being diagnosed with gonorrhea, which carries its own stigma and relationship implications. Patients may need to disclose the diagnosis to sexual partners, navigate contact tracing, and cope with the surprise of learning that a genital infection traveled to their eye. Clinicians who treat these patients play a role not just in prescribing antibiotics but in connecting them with sexual health services and ensuring partners are treated, a step that roughly half of patients in the Scottish cohort did not complete on their own.18Nature (Eye). Five-year review of ocular Neisseria gonorrhoeae infections presenting to ophthalmology departments in Greater Glasgow & Clyde, Scotland